Bill Snyder Archive — Page 107 of 120
-
October 24, 2013
Study sheds new light on type 2 diabetes development
Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found. -
October 21, 2013
Frisse, Weiner elected to Institute of Medicine
Vanderbilt University’s Betsy Weiner, Ph.D., R.N., senior associate dean for Informatics in the School of Nursing, and Mark Frisse, M.D., MS, MBA, Accenture Professor and director of Regional Informatics, have been elected to the Institute of Medicine (IOM), the organization announced this week. -
October 17, 2013
Weill Cornell’s Glimcher awarded Vanderbilt Prize
The 2013 Vanderbilt Prize in Biomedical Science has been awarded to Laurie Glimcher, M.D., Stephen and Suzanne Weiss Dean and professor of Medicine at Weill Cornell Medical College in New York City. -
October 17, 2013
Synthetic biology expert Collins set to speak at Vanderbilt
Boston University biomedical engineer and MacArthur Fellow James Collins, Ph.D., will lecture at 3:10 p.m. Oct. 23 in the Jacobs Believed in Me Auditorium, part of the Vanderbilt School of Engineering’s Featheringill Hall. -
October 11, 2013
New target for stopping inflammation
Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. -
October 10, 2013
Clinical and translational research highlighted at retreat
Kathleen Neuzil, M.D., MPH, known internationally for her efforts to expand vaccine access and delivery around the world, credited her Vanderbilt University mentors last week for guiding her to a career path that allowed her to “make a difference.”